<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02149407</url>
  </required_header>
  <id_info>
    <org_study_id>0752</org_study_id>
    <nct_id>NCT02149407</nct_id>
  </id_info>
  <brief_title>Glycerin Suppositories for Treatment of Feeding Intolerance in Preterm Infants</brief_title>
  <official_title>Efficacy and Safety of Glycerin Suppositories for Treatment of Feeding Intolerance in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Saud Medical City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sulaiman Al Habib Medical Group- Arrayan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King Saud Medical City</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feeding intolerance is a common problem in preterm infants.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to full feeding (days)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 3 weeks</time_frame>
    <description>Days to achieve full enteral feeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of feeding intolerance</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
    <description>Feeding intolerance defined as feeding withheld, discontinued, or decreased because the infant was not tolerating enteral feedings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of necrotizing enterocolitis (NEC)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <description>Necrotizing enterocolitis (NEC) defined as per Bell's staging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of proven late onset infection</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <description>Incidence of proven late onset infection defined as clinical signs in addition to positive blood culture beyond 72 hours of age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hyperbilirubinemia</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <description>Incidence of hyperbilirubinemia defined as level of bilirubin requiring treatment with phototherapy according to the bilirubin chart used in the participating unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay (days)</measure>
    <time_frame>At discharge from hospital, an expected average of 8 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Growth at discharge from hospital</measure>
    <time_frame>At discharge from hospital, an expected average of 8 weeks</time_frame>
    <description>Growth parameters at discharge from hospital include: Weight (grams), Length (cm), and Head circumference (cm)</description>
  </other_outcome>
  <other_outcome>
    <measure>Retinopathy of prematurity (ROP)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <description>Defined by the International Classification of Retinopathy of Prematurity (ICORP)</description>
  </other_outcome>
  <other_outcome>
    <measure>Bronchopulmonary dysplasia (BPD)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patent ductus arteriosus (PDA)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <description>Diagnosed by echocardiogram</description>
  </other_outcome>
  <other_outcome>
    <measure>Side effects</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
    <description>For example: Rectal bleeding, Rectal Perforation, or Hematochezia</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Feeding Intolerance</condition>
  <arm_group>
    <arm_group_label>Glycerin group (GG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glycerin group &quot;GG&quot; will receive the 0.5 suppository (700 mg) twice daily for 48 hours. We will use the rounded part and discard the other part then will hold baby's buttocks for 2 minutes to ensure its delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rectal stimulation group (SG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rectal stimulation &quot;SG&quot; by soft cotton swab inserted to around 3 cm. The stick will press against the rectal wall in all direction for 2 minutes twice daily for 48 hours. Ky gel will be used to lubricate the stick and minimize direct friction to rectal wall.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group (CG)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Control group &quot;CG&quot; will receive routine NICU medical care without any specific intervention for the infant. The research nurse will do shame placebo twice daily by opening his diaper to blind the team for 2 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycerin</intervention_name>
    <description>Glycerin group &quot;GG&quot; will receive the 0.5 suppository (700 mg) twice daily for 48 hours. We will use the rounded part and discard the other part then will hold baby's buttocks for 2 minutes to ensure its delivery.</description>
    <arm_group_label>Glycerin group (GG)</arm_group_label>
    <other_name>Glycerine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rectal stimulation</intervention_name>
    <description>Rectal stimulation &quot;SG&quot; by soft cotton swab inserted to around 3 cm. The stick will press against the rectal wall in all direction for 2 minutes twice daily for 48 hours. Ky gel will be used to lubricate the stick and minimize direct friction to rectal wall.</description>
    <arm_group_label>Rectal stimulation group (SG)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Control group &quot;CG&quot; will receive routine NICU medical care without any specific intervention for the infant. The research nurse will do shame placebo twice daily by opening his diaper to blind the team for 2 minutes.</description>
    <arm_group_label>Control group (CG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants with birth weight equal or less than 1500 g

        Exclusion Criteria:

          -  Significant congenital malformations

          -  Severity of illness such that death is likely in the first few days after birth
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Latifa Almahmoud, MD</last_name>
    <role>Study Chair</role>
    <affiliation>KSMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasim Anabrees</last_name>
    <email>jasim1800@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>King Saud Medical City</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Latifa Almahmoud</last_name>
      <email>latifa369@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>latifa Almahmoud</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haider Somaily</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nabeel Al-Odaisan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sadia Al-Shehri</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sulaiman Al Habib Medical Group</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jasim Anabrees, FRCPCH</last_name>
      <email>jasim1800@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Jasim Anabrees, FRCPCH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2014</study_first_submitted>
  <study_first_submitted_qc>May 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2014</study_first_posted>
  <last_update_submitted>April 2, 2015</last_update_submitted>
  <last_update_submitted_qc>April 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

